Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Stroke Is Better Than Low Doses [Clinical Sciences]

Conclusions—
Our study suggests that standard-dose intravenous tPA for stroke had more favorable outcome without increasing the risk of symptomatic intracranial hemorrhage than low-dose tPA. For Asian people, 0.9 mg/kg should be the optimal dose of tPA to treat acute ischemic stroke.

Source: Stroke - July 28, 2014 Category: Neurology Authors: Liao, X., Wang, Y., Pan, Y., Wang, C., Zhao, X., Wang, D. Z., Wang, C., Liu, L., Wang, Y., on behalf of the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China Investigators Tags: Acute Cerebral Infarction, Thrombolysis Clinical Sciences Source Type: research